Research and Markets: The New Age of Regenerative Medicine – Why Stem Cell Therapy?

DUBLIN

Research and Markets (http://www.researchandmarkets.com/research/vv7w8d/seg3d_the_new_age) has announced the addition of the “Seg3D The New Age of Regenerative Medicine” report to their offering.

Cell therapy is the fastest growing segment of the Regenerative Medicine (RM) industry. It comprises both immune cell therapy and stem cell therapy; however, stem cell therapy makes up the largest part of this segment. The global cell therapy market is driven by the success of stem cell treatments in treating or curing life-threatening diseases such as cancer, heart disease, and neuro-muscular ailments among the aging population. This research study provides an overview of the regenerative medicine industry and an insight on successful stem cell therapy treatments. It also analyses marketed products, stem cell manufacturing and funding, and the collaborative partnerships in the regenerative medicine industry.

Key Findings

• Regenerative Medicine (RM) represents a new human-health paradigm with the potential to resolve unmet medical needs by addressing the underlying causes of diseases.
• Globally, there are over companies focused on regenerative medicine. The United States has the most registered RM companies, followed by the United Kingdom, Germany and Japan.
• Rapidly growing medical tourism, contract research outsourcing, and a rising population of patients with neurological and other chronic conditions are some of the factors driving the Asian stem cells market.

Key Questions This Study Will Answer

• What are some of the key developments impacting the regenerative medicine industry?
• What are some of the key regulatory changes affecting the regenerative medicine industry?
• How are investments and market consolidations progressing in Asia-Pacific?
• What are some of the key participants making an impact in the regenerative medicine industry?

Key Topics Covered:

1. Executive Summary
2. The New Age of Regenerative Medicine – An Overview
3. Stem Cell Manufacturing Facilities – Market Dynamics
4. Stem Cell Consumers
5. Future Trends
6. Regenerative Medicine Industry – Mergers, Acquisitions, and Partnership Assessment
7. Regenerative Medicine Industry – Funding Scenario
8. Overview of Regenerative Medicine in Asia-Pacific
9. Conclusion

Companies Mentioned

• MEDIPOST Co., Ltd.
• Mesoblast Ltd.
• Cellular Dynamics International (CDI)
• Orthofix International
• Capricor Therapeutics

For more information visit http://www.researchandmarkets.com/research/vv7w8d/seg3d_the_new_age

View source version on businesswire.com: http://www.businesswire.com/news/home/20150909005717/en/

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Stem Cells